NCT06475872View on ClinicalTrials.gov

"Study to Evaluate the Bioequivalence of Crecheck Tablet 2.5 mg (Rosuvastatin Calcium) and Crestor Tablet 5 mg (Rosuvastatin Calcium) in Healthy Adult Subjects"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

December 7, 2023

Study Completion Date

December 7, 2023

Conditions

Primary HypercholesterolemiaCombined Hyperlipidemia

Interventions

DRUG

Crecheck Tablet 2.5 mg

2 tablets orally once a day

DRUG

Crestor Tablet 5 mg

1 tablet orally once a day

Trial Locations (1)

15079

Seok Gyeong Medical Foundation Central Hospital, Gyeonggi-do

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT06475872 - "Study to Evaluate the Bioequivalence of Crecheck Tablet 2.5 mg (Rosuvastatin Calcium) and Crestor Tablet 5 mg (Rosuvastatin Calcium) in Healthy Adult Subjects" | Biotech Hunter | Biotech Hunter